{
    "clinical_study": {
        "@rank": "68840", 
        "acronym": "P&T", 
        "arm_group": [
            {
                "arm_group_label": "Prevention & Testing Control", 
                "arm_group_type": "Active Comparator", 
                "description": "The comparison condition is focused on basic HIV risk reduction , safety and preventing drug overdose."
            }, 
            {
                "arm_group_label": "Prevention & Testing Intervention", 
                "arm_group_type": "Experimental", 
                "description": "The intervention condition is training on peer outreach skills which includes talking to HIV positive social  network members about HIV care, medication adherence and HIV risk reduction."
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of this study is to conduct an HIV prevention intervention to train HIV\n      seropositive drug users to be peer health educators."
        }, 
        "brief_title": "A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "HIV", 
        "detailed_description": {
            "textblock": "The primary objective of this funded research is to conduct an HIV prevention intervention\n      to train HIV seropositive drug users to be peer health educators to: (1) recruit their high\n      risk social network members for voluntary HIV counseling and testing (VCT) at the research\n      clinic, (2) promote risk reduction among social network members, and (3) promote engagement\n      in HIV care by encouraging HIV seropositive network members to schedule and keep HIV primary\n      care appointments.  There will be four types of participants in the Full Trial:  1) Index,\n      2) Testing Network 3) Longitudinal Network and 4) HIV positive network participants. This\n      longitudinal study includes baseline, 6-months, and 12-month assessments"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Index\n\n          1. 18 years old or older\n\n          2. documentation of HIV positive status\n\n          3. report one of following risk behaviors in past 90 days: sharing injection equipment,\n             use of crack cocaine, or unprotected vaginal or anal sex\n\n        Testing network\n\n          1. 18 or older\n\n          2. provided testing coupon  provided by an index participant\n\n        Longitudinal network participant-\n\n          1. tested HIV negative at the Lighthouse via redeeming a testing coupon\n\n          2. reported interacting with index who gave the coupon at least weekly\n\n          3. report one of following risk behaviors in  the prior 90 days: sharing injection\n             equipment, use of crack cocaine, or unprotected vaginal or anal sex\n\n        Positive Networks\n\n          1. HIV positive\n\n          2. report one of following risk behaviors in  the prior 90 days: sharing injection\n             equipment, use of crack cocaine, or unprotected vaginal or anal sex\n\n        Exclusion Criteria:\n\n        Index- already enrolled in the study as a Network participant\n\n        Testing network- already enrolled in the study as a Network participant\n\n        Longitudinal network- a) already enrolled in the study as a Network participant b) already\n        enrolled in the study as a Index participant\n\n        Positive network-  a) already enrolled in the study as a Network participant b) already\n        enrolled in the study as a Index participant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01935440", 
            "org_study_id": "R01DA032217", 
            "secondary_id": "R01DA032217"
        }, 
        "intervention": [
            {
                "arm_group_label": "Prevention & Testing Intervention", 
                "description": "6 group sessions, 1 individual  session, and 1 dyad session", 
                "intervention_name": "Prevention & Testing", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Prevention & Testing Control", 
                "description": "7 group sessions", 
                "intervention_name": "Prevention & Testing Control", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "HIV, drug use", 
        "lastchanged_date": "August 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21205"
                }, 
                "name": "Lighhouse Studies @ Peer Point"
            }, 
            "investigator": {
                "last_name": "Carl Latkin, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "clatkin@jhsph.edu", 
            "last_name": "Carl Latkin, PhD", 
            "phone": "410-502-5368"
        }, 
        "overall_official": {
            "affiliation": "Johns Hopkins Bloomberg School of Public Health", 
            "last_name": "Carl A Latkin, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "change in HIV medication adherence", 
                "safety_issue": "No", 
                "time_frame": "6 month"
            }, 
            {
                "measure": "change in frequency in attending HIV medical appointments", 
                "safety_issue": "No", 
                "time_frame": "6 month"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01935440"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins Bloomberg School of Public Health", 
            "investigator_full_name": "Carl Latkin", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "change in sharing injection equipment", 
                "safety_issue": "No", 
                "time_frame": "6 month"
            }, 
            {
                "measure": "change in condom use", 
                "safety_issue": "No", 
                "time_frame": "6 month"
            }
        ], 
        "source": "Johns Hopkins Bloomberg School of Public Health", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Johns Hopkins Bloomberg School of Public Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}